It appears that the Achillion Pharma (ACHN) stock is no longer trading actively as of date of writing. It may be because the stock trading may have been discontinued by the issuing organization, or may have been suspended from active trading owing to a variety of reasons, or it may be an error in FKnol.com records (please let us know). The following data about this stock is available as of writing in FKnol.com records, and may be obsolete. Achillion Pharma has the following business profile:
Market and Trading Information for Achillion Pharma
The following details were available for trading and market data about the stock of Achillion Pharma as of writing:
Trading Details of Achillion Pharma (ACHN)
Current Share Price:
$6.76
Previous Year's Closing Price:
$6.03
Percentage Price Change (YTD):
12.11%
Market Cap:
$947.02 million
52-week Price Range:
$2.35 - $7.01
Dividend Per Share:
$0
EPS (TTM):
-0.54
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
-8.67
Company Profile and Business Description for Achillion Pharma
Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. The Company is focused on its complement inhibitor platfor...to see full details, pleaseLogin / Register to view.
ETFs Holding Achillion Pharma Stock
As of March 2020, the following exchange-traded funds (ETF) hold the Achillion Pharma stocks in their respective portfolios. See Full List.
The iShares NASDAQ Biotechnology ETF tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. ...Full Details ...Candlestick Patterns.
The NuShares ESG Small-Cap ETF tracks a multi-factor-weighted index of small-cap companies listed on US exchanges. Holdings are screened for environmental, social, and governance criteria. ...Full Details
See Full List of ETFs holding Achillion Pharma stock in their respective portfolios.
U.S. Stock Screener:
Peer / Competitor Companies of Major Pharmaceuticals Sector
Along with Achillion Pharmaceuticals, Inc., the following other peer (competitor) companies also exist within the same Major Pharmaceuticals - Healthcare sector whose company profile and dividend history is as follows:
▶ Abbott Labs (ABT): Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical ....See Detailed Company Profile, Dividend History and Recent Candlestick Patterns.
▶ AbbVie (ABBV): AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ....See Detailed Company Profile, Dividend History and Recent Candlestick Patterns.
▶ Abeona Therapeutics (ABEO): Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ....See Detailed Company Profile, Dividend History
▶ AC Immune SA (ACIU): AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ....See Detailed Company Profile, Dividend History
▶ ACADIA Pharma (ACAD): ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ....See Detailed Company Profile, Dividend History
▶ Acasti Pharma (ACST): Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ....See Detailed Company Profile, Dividend History
▶ AcelRx Pharma (ACRX): AcelRx Pharmaceuticals, Inc., incorporated on July 13, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company ....See Detailed Company Profile, Dividend History
▶ Aclaris Therapeutics (ACRS): Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ....See Detailed Company Profile, Dividend History
▶ Actinium Pharma (ATNM): Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ....See Detailed Company Profile, Dividend History
▶ Acura Pharma (ACUR): Acura Pharmaceuticals, Inc., incorporated on April 10, 1935, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication ....See Detailed Company Profile, Dividend History
▶ Adamas Pharma (ADMS): Adamas Pharmaceuticals, Inc., incorporated on November 15, 2000, is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic ....See Detailed Company Profile, Dividend History
▶ Adamis Pharma (ADMP): Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products ....See Detailed Company Profile, Dividend History
▶ Aduro Biotech (ADRO): Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ....See Detailed Company Profile, Dividend History
▶ Advaxis (ADXS): Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ....See Detailed Company Profile, Dividend History
▶ Aeglea BioTherapeutics (AGLE): Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ....See Detailed Company Profile, Dividend History
▶ AEterna Zentaris (AEZS): Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and womens health. The Company operates through the ....See Detailed Company Profile, Dividend History
▶ Affimed (AFMD): Affimed N.V., incorporated on May 1, 2014, is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Companys product candidates are developed in the field of immuno-oncology, ....See Detailed Company Profile, Dividend History
▶ Agile Therapeutics (AGRX): Agile Therapeutics, Inc., incorporated on December 5, 1997, is a womens health specialty pharmaceutical company. The Company is focused on the development and commercialization of prescription contraceptive products. Its product ....See Detailed Company Profile, Dividend History
▶ Agios Pharma (AGIO): Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ....See Detailed Company Profile, Dividend History
▶ Aimmune Therapeutics (AIMT): Aimmune Therapeutics, Inc., incorporated on June 24, 2011, is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other ....See Detailed Company Profile, Dividend History